Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 510.65
(1.72%)
INR 510.65
(1.72%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.17 Billion INR | -52.31% |
| 2022 | 2.46 Billion INR | -16.17% |
| 2021 | 2.93 Billion INR | 76.31% |
| 2020 | 1.66 Billion INR | -32.14% |
| 2019 | 2.45 Billion INR | 9.11% |
| 2018 | 2.25 Billion INR | -7.35% |
| 2017 | 2.42 Billion INR | 0.0% |
| 2016 | - INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 792.6 Million INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 1.17 Billion INR | -52.31% |
| 2023 Q4 | 1.17 Billion INR | 0.0% |
| 2023 Q2 | 1.91 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 2.41 Billion INR | 0.0% |
| 2022 FY | 2.46 Billion INR | -16.17% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 2.46 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 2.93 Billion INR | 76.31% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 2.57 Billion INR | 0.0% |
| 2021 Q4 | 2.93 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 1.66 Billion INR | -32.14% |
| 2020 Q4 | 1.66 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 2.48 Billion INR | 0.0% |
| 2019 Q2 | 2.11 Billion INR | 0.0% |
| 2019 FY | 2.45 Billion INR | 9.11% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 2.45 Billion INR | -23.37% |
| 2019 Q3 | 3.2 Billion INR | 51.71% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 2.25 Billion INR | -7.35% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 2.6 Billion INR | 0.0% |
| 2018 Q4 | 2.25 Billion INR | 0.0% |
| 2017 Q4 | 2.42 Billion INR | 23.1% |
| 2017 Q3 | 1.97 Billion INR | 0.0% |
| 2017 FY | 2.42 Billion INR | 0.0% |
| 2016 FY | - INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -3542.254% |
| Aarti Drugs Limited | 2.75 Billion INR | 57.346% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -293500.0% |
| Ajanta Pharma Limited | 235.2 Million INR | -399.32% |
| Alembic Limited | 73.9 Million INR | -1489.175% |
| Alkem Laboratories Limited | 400 Million INR | -193.6% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -86.768% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -4118.997% |
| Bal Pharma Limited | 363.82 Million INR | -222.793% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -229.96% |
| Brooks Laboratories Limited | 3.56 Million INR | -32842.496% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -992.14% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -12665.217% |
| Divi's Laboratories Limited | 20 Million INR | -5772.0% |
| Eris Lifesciences Limited | 6.54 Billion INR | 82.057% |
| Granules India Limited | 689.71 Million INR | -70.274% |
| Ind-Swift Limited | 10.09 Billion INR | 88.367% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -1454.056% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -396.785% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 96.292% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Medicamen Biotech Limited | 12.55 Million INR | -9254.042% |
| Medico Remedies Limited | 8.67 Million INR | -13442.435% |
| Wockhardt Limited | 8.91 Billion INR | 86.819% |
| Orchid Pharma Limited | 1.2 Billion INR | 2.483% |
| RPG Life Sciences Limited | -30.3 Million INR | 3975.908% |
| Shilpa Medicare Limited | 5.6 Billion INR | 79.035% |
| Sigachi Industries Limited | 265.79 Million INR | -341.839% |
| Unichem Laboratories Limited | 382.22 Million INR | -207.257% |
| Vaishali Pharma Limited | 35.98 Million INR | -3163.763% |
| Wanbury Limited | 820 Million INR | -43.22% |
| Zydus Lifesciences Limited | 251 Million INR | -367.888% |
| FDC Limited | 2.46 Million INR | -47523.682% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -8307.789% |
| Bajaj HealthCare Limited | 650.34 Million INR | -80.581% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 80.394% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -695.61% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -952.085% |
| Laurus Labs Limited | 7.98 Billion INR | 85.287% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -779.43% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 16.299% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Hester Biosciences Limited | 1.81 Billion INR | 35.392% |
| Ipca Laboratories Limited | 5.8 Billion INR | 79.766% |
| Venus Remedies Limited | 386.8 Million INR | -203.619% |
| ZIM Laboratories Limited | 356 Million INR | -229.882% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 94.499% |
| Morepen Laboratories Limited | 33.64 Million INR | -3391.082% |
| Neuland Laboratories Limited | 449.2 Million INR | -161.439% |
| Sequent Scientific Limited | 1.42 Billion INR | 17.712% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -453.034% |
| Valiant Laboratories Limited | 750.89 Million INR | -56.399% |
| Windlas Biotech Limited | 20.18 Million INR | -5719.623% |
| Hikal Limited | 4.22 Billion INR | 72.227% |
| Innova Captab Limited | 2.1 Billion INR | 44.214% |
| Procter & Gamble Health Limited | 68.8 Million INR | -1606.977% |
| Themis Medicare Limited | 267.74 Million INR | -338.634% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 325.81 Million INR | -260.45% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 22.579% |
| Sakar Healthcare Limited | 549.55 Million INR | -113.702% |
| Albert David Limited | 6.01 Million INR | -19421.277% |
| Lupin Limited | 1.55 Billion INR | 24.369% |
| Gufic Biosciences Limited | 1.53 Billion INR | 23.722% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -8730.075% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 96441.263% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.781% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 92.678% |
| NATCO Pharma Limited | 53 Million INR | -2115.849% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 36.0% |
| Strides Pharma Science Limited | 6.71 Billion INR | 82.511% |
| Indoco Remedies Limited | 3.51 Billion INR | 66.611% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -1001.689% |